Gemcitabine resistance in pancreatic cancer: picking the key players

Clin Cancer Res. 2008 Mar 1;14(5):1284-5. doi: 10.1158/1078-0432.CCR-07-2247.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / metabolism
  • Animals
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Carcinoma, Pancreatic Ductal / drug therapy*
  • Carcinoma, Pancreatic Ductal / metabolism
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Drug Resistance, Neoplasm*
  • Gemcitabine
  • HMGA Proteins / metabolism
  • Humans
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / metabolism

Substances

  • Antimetabolites, Antineoplastic
  • HMGA Proteins
  • Deoxycytidine
  • Gemcitabine